Metraipolis › archive › dc_f3ea565b5d94
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer… — Europe PMC PMID:42828095
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42828095
- DOI
- 10.1016/j.esmorw.2026.100783
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-06T07:52:17.646Z
- SHA-256 of the archived text
641df4d04aead490d6aa4e48badeb7fe33149f14c29b1e915c71c8fa9b359c1b- Stable URL of this page
https://metraipolis.com/documento/dc_f3ea565b5d94
How to cite
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer… — Europe PMC PMID:42828095 — Europe PMC (en), https://europepmc.org/article/MED/42828095 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f3ea565b5d94 (Metraipolis archive dc_f3ea565b5d94, sha256 641df4d04aead490d6aa4e48badeb7fe33149f14c29b1e915c71c8fa9b359c1b)
BibTeX
@misc{dcf3ea565b5d94,
title = {Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer… — Europe PMC PMID:42828095},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42828095},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f3ea565b5d94; sha256 641df4d04aead490d6aa4e48badeb7fe33149f14c29b1e915c71c8fa9b359c1b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42828095. Agents can read the archived copy with the MCP tool read_document.